Keymed Biosciences Inc. (HKG:2162)
Hong Kong · Delayed Price · Currency is HKD 77.75
+0.70 (0.91%)
Aug 20, 2026, 4:09 PM HKT
Keymed Biosciences Market Cap
Keymed Biosciences has a market cap or net worth of 22.91 billion as of August 20, 2026. Its market cap has increased by 4.01% in one year.
Market Cap
22.91B
Enterprise Value
19.98B
Revenue
963.56M
Ranking
n/a
PE Ratio
24.88
Stock Price
77.75
ChartMarket Cap Chart
Since July 8, 2021, Keymed Biosciences's market cap has increased from 18.43B to 22.91B, an increase of 24.30%. That is a compound annual growth rate of 4.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 22.91B | 45.46% |
| Dec 31, 2025 | 15.75B | 84.90% |
| Dec 31, 2024 | 8.52B | -37.32% |
| Dec 29, 2023 | 13.59B | -4.15% |
| Dec 30, 2022 | 14.17B | 46.87% |
| Dec 31, 2021 | 9.65B | -47.63% |
| Jul 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3SBio | 43.54B |
| Shanghai Junshi Biosciences | 40.02B |
| Shanghai Henlius Biotech | 37.39B |
| InnoCare Pharma | 30.78B |
| Zai Lab | 22.58B |
| Duality Biotherapeutics | 16.82B |
| Nanjing Leads Biolabs | 14.90B |
| Metis TechBio | 14.76B |